This inventor holds 1 USPTO granted patent. Top assignees: Hoya Technosurgical Corporation, Other. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Takehiko Nakajima: Innovator in Organ Regeneration Technology
Introduction
Takehiko Nakajima is a prominent inventor based in Ibaragi, Japan. He is known for his groundbreaking work in the field of organ regeneration. His innovative approach has the potential to revolutionize medical treatments for organ defects.
Latest Patents
Takehiko Nakajima holds a patent for an organ regeneration device. This device is designed to be placed into a defective portion of an organ to facilitate regeneration. The device features a base body that corresponds to the shape of the defective area. It also includes particles made from a different material than the base body. Additionally, the device contains a growth-related substance that promotes the growth and differentiation of cells around the defective portion. This growth-related substance includes an angiogenesis factor and nucleic acid that codes for a growth factor's amino-acid sequence. The nucleic acid is introduced into a host cell, enhancing the regenerative process.
Career Highlights
Throughout his career, Takehiko Nakajima has made significant contributions to the field of medical technology. His work has garnered attention for its innovative solutions to complex medical challenges. He has been involved in various projects that focus on improving organ health and functionality.
Collaborations
Takehiko Nakajima has collaborated with notable individuals in his field, including Ichiro Ono and Yoshikiyo Akasaka. These collaborations have furthered his research and development efforts in organ regeneration technology.
Conclusion
Takehiko Nakajima's contributions to organ regeneration technology highlight his role as a leading inventor in the medical field. His innovative devices and collaborative efforts pave the way for advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile